NCT04687475Completed
Implementation of a Clinical Tool to Improve Waitlist Mortality in Patients With Cystic Fibrosis
Source: ClinicalTrials.gov · Last updated 29 Jul 2026
Brief summary (registry, in English)
Implementation of a Clinical Tool to Improve Waitlist Mortality in Patients With Cystic Fibrosis
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 10 (actual)
- First submitted
- 17 Dec 2020
- Start date
- 20 Apr 2020
- Primary completion date
- 1 Feb 2026
- Lead sponsor
- The Cleveland Clinic
- Diseases
- Cystic fibrosis
- NCT number
- NCT04687475
What you commit to
- Study type: Interventional
- Participants enrolled: 10
- From 20 Apr 2020 to the primary completion date, 1 Feb 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Diagnosis other than Cystic Fibrosis
- Unable to read
- Unable to use computer or smartphone device to access mobile application
Who the study is looking for
- Diagnosis of Cystic Fibrosis
- To be listed for lung transplant
- Has purchased home spirometer
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Cleveland Clinic Coordinator of this site? Confirm its status | Cleveland | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.